News

Pfizer has announced that the US Securities and Exchange Commission (SEC) has declared effective Pfizer’ Registration Statement on Form S-4. The Form S-4 registers with the SEC Pfizer’s

Amsterdam Molecular Therapeutics’ (AMT) lead product ,Glybera, has demonstrated long-term health benefits in one-time administration. The data from two clinical trials showed that one administration with Glybera brings

Manhattan Pharmaceuticals (Manhattan) has provided update on ongoing development program for Hedrin. Hedrin is a next generation, non-pesticide treatment for Pediculosis (head lice). The drug is currently being

New Jersey, US- based Strativa ,the proprietary products division of a wholly owned subsidiary of Par declared that its development partner, BioAlliance has submitted a New Drug Application

Mylan Pharmaceuticals, a subsidiary of Mylan has received approval from the FDA for supplemental Abbreviated New Drug Application (ANDA) for Temazepam Capsules USP, 22.5 mg. This strength is

The US Federal Trade Commission has granted Johnson & Johnson, the early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act, with respect to its previously

Xcellerex has announced that Crucell is acquiring a FlexFactory bioproduction line and multiple XDR single-use bioreactors, to expand the manufacturing capabilities. The project will deliver new, validated clinical

Global Alliance for TB and Tibotec have enterned into a partnership to accelerate the discovery and development of new drugs for tuberculosis (TB). The two organizations will share

Cepheid has released its improved Xpert BCR-ABL Monitor test, to be marketed as a CE IVD product under the European Directive. It is intended to aid European clinicians